Patents by Inventor Herbert Höpfl

Herbert Höpfl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10207982
    Abstract: The present invention refers to new amorphous and crystalline solid forms of desvenlafaxine, also known as O-desmethylvenlafaxine or desmethylvenlafaxine, and to its salts, solvates, hydrates and polymorphs thereof, as well as to their use in the manufacture of a pharmaceutical composition useful in the treatment of depression and/or as a selective serotonin and norepinephrine reuptake inhibitor and also in menopause-associated vasomotor disorders.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: February 19, 2019
    Assignee: Alparis, S.A. DE C.V.
    Inventors: Jorge Guillermo Domínguez Chávez, Karina Mondragón Vásquez, Hugo Morales Rojas, Dea Herrera Ruiz, Herbert Höpfl, Reyna Reyes Martínez, Javier Hernández Illescas, Juan Pablo Senosiain Peláez
  • Publication number: 20180002273
    Abstract: The present invention refers to new amorphous and crystalline solid forms of desvenlafaxine, also known as O-desmethylvenlafaxine or desmethylvenlafaxine, and to its salts, solvates, hydrates and polymorphs thereof, as well as to their use in the manufacture of a pharmaceutical composition useful in the treatment of depression and/or as a selective serotonin and norepinephrine reuptake inhibitor and also in menopause-associated vasomotor disorders.
    Type: Application
    Filed: June 29, 2017
    Publication date: January 4, 2018
    Inventors: Jorge Guillermo DOMÍNGUEZ CHÁVEZ, Karina MONDRAGÓN VÁSQUEZ, Hugo MORALES ROJAS, Dea HERRERA RUIZ, Herbert HÖPFL, Reyna REYES MARTÍNEZ, Javier HERNÁNDEZ ILLESCAS, Juan Pablo SENOSIAIN PELÁEZ
  • Patent number: 9290492
    Abstract: The invention relates to novel solid forms of fluoroquinolones, in particular to complex co-crystals and to solvates, hydrates and polymorphs thereof. These substances can be used to prepare a pharmaceutical composition containing same as an active ingredient, which can be used as an antibiotic. The compounds have a storage stability that is constant and above that of the salts or hydrates thereof.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: March 22, 2016
    Assignee: Laboratorios Senosiain S.A. de C.V.
    Inventors: Hugo Morales Rojas, Jorge Guillermo Domínguez Chávez, Dea Herrera Ruiz, Herbert Höpfl, Juan Manuel Martínez Alejo, Juan Pablo Senosiain Peláez
  • Patent number: 9278970
    Abstract: The present invention relates to co-crystals of tadalafil with hydroxyl-substituted benzoic acid coformers having the following structure. Said co-crystals can be used to produce a pharmaceutical composition containing the same as the useful active ingredient. Said co-crystals can exhibit a constant storage stability.
    Type: Grant
    Filed: July 6, 2013
    Date of Patent: March 8, 2016
    Assignee: Laboratorios Senosiain S.A. de C.V.
    Inventors: Dea Herrera Ruiz, Karina Mondragón Vásquez, Hugo Morales Rojas, Herbert Höpfl, Juan Pablo Senosiain Peláez
  • Publication number: 20140088116
    Abstract: The invention relates to novel solid forms of fluoroquinolones, in particular to complex co-crystals and to solvates, hydrates and polymorphs thereof. These substances can be used to prepare a pharmaceutical composition containing same as an active ingredient, which can be used as an antibiotic. The compounds have a storage stability that is constant and above that of the salts or hydrates thereof.
    Type: Application
    Filed: April 27, 2012
    Publication date: March 27, 2014
    Applicant: LABORATORIOS SENOSIAIN S.A. DE C.V.
    Inventors: Hugo Morales Rojas, Jorge Guillermo Domínguez Chávez, Dea Herrera Ruiz, Herbert Höpfl, Juan Manuel Martínez Alejo, Juan Pablo Senosiain Peláez